A decision-ready blueprint
A Search and Generative programme designed around the commercial realities of cell & gene therapy developers.
Scientific, commercial, and digital architecture, with specialist expertise assembled where the engagement requires it.
Cell and gene therapy developers need prospective partners and investors to find, understand, and accurately assess complex scientific, clinical, and commercial evidence. Search and Generative Engine Optimization creates the evidence and content architecture that supports that discovery work across search, answer engines, and specialist diligence workflows.
Lonrú Consulting builds a governed S/GEO programme around the questions a company needs its public presence to answer. The work connects approved scientific claims, clinical and regulatory context, competitive differentiation, and measurement, so the most relevant published material is clear, traceable, and ready to support commercial engagement.
We define the approved scientific, clinical, regulatory, commercial, and published sources that support the programme, together with claim ownership, permissions, and the questions the company needs to answer.
Configured systems analyse approved material, identify information gaps and search intent, and prepare structured content components for review within the agreed evidence boundaries.
Lonrú provides principal-led strategy and review governance. Client scientific, clinical, regulatory, and commercial SMEs review the material that sits within their areas of accountability.
The programme is delivered through a usable evidence and content system, supported by performance views that help teams assess search visibility, audience questions, and the next priority.
Structure the approved evidence behind a modality, platform, development programme, or manufacturing advantage so relevant audiences can find the right source material.
Connect publications, trial information, company material, and approved commercial context without flattening the scientific detail that informs partnering and investment discussions.
Build pages and supporting assets around the questions prospective partners, investors, and scientific peers need answered, with clear sources and accountable review.
Use search, engagement, and content-performance signals to identify where the public evidence base is clear, where it needs strengthening, and what should be prioritised next.
S/GEO does not control how a third-party search or answer engine ranks an organisation. It gives the company a more coherent, accurate, and evidence-led public presence that can be discovered, interpreted, and cited with greater confidence.
We start with approved material and a defined commercial question. Proprietary information remains within the agreed engagement boundaries, and published claims remain subject to the appropriate scientific, regulatory, and commercial review.
Relevant experience
Search and generative
Establish a practical measurement system for how a company, therapy, or evidence base appears in traditional search, AI Overviews, and relevant LLM-led discovery journeys. Track the questions, sources, pages, and signals shaping that visibility, then use the findings to improve content, evidence structure, and commercial relevance.
Interactive SaaS
Engineered and deployed an interactive SaaS trial-tracking platform, VantagePoint Insights™, with an advanced-therapy Voice of Customer database that maps pipeline maturity, modality, and vector dominance for industry stakeholders.
Architecture in context
Diagram summary: Approved scientific, clinical, and commercial evidence is contextualised, analysed, and tested through ActiveArchitecture™ before it supports clearer discovery by prospective partners and investors.
Practical questions
Next step
Bring the decision, workflow, or delivery constraint that needs a clearer operating path.
Request a focused briefing